Los péptidos natriuréticos en el diagnóstico de la insuficiencia cardíaca en atención primariaArt. 101812

  1. M. Turégano-Yedro 1
  2. A. Ruiz-García 2
  3. M.J. Castillo-Moraga 3
  4. E. Jiménez-Baena 4
  5. V. Barrios 5
  6. A. Serrano-Cumplido 6
  7. V. Pallarés-Carratalá 7
  1. 1 Centro de Salud Aldea Moret, Cáceres, España
  2. 2 Centro de Salud Universitario Pinto, Pinto, Madrid, España
  3. 3 Centro de Salud Sanlúcar Barrio Bajo, Sanlúcar de Barrameda, Cádiz, España
  4. 4 Servicio de Cardiología, Hospital Ciudad de Coria, Coria, Cáceres, España
  5. 5 Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, España
  6. 6 Medicina de Familia y Comunitaria, Getxo, Bizkaia, España
  7. 7 Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España
Mostrar afiliaciones +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Año de publicación: 2022

Número: 7

Páginas: 9-9

Tipo: Artículo

DOI: 10.1016/J.SEMERG.2022.101812 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Semergen: revista española de medicina de familia

Objetivos de desarrollo sostenible

Resumen

Heart failure (HF) is a clinical syndrome characterized by symptoms and signs caused by structural and/or functional abnormalities of the heart that cause reduced cardiac output and/or elevated intracardiac pressures at rest or during exercise. Its prevalence and incidence are increasing and it is the leading cause of hospitalization in people over 65 years of age. The new American and European guidelines for the management of HF emphasize that the measurement of natriuretic peptide (NP) concentrations constitutes a cornerstone of the diagnostic management of HF, and that the history, physical examination, electrocardiogram, and chest X-ray, complete the beginning of the HF diagnostic process. All these actions and diagnostic tests can be performed and requested from the primary care office. The authors of this document, on behalf of the SEMERGEN Hypertension and Cardiovascular Disease Working Group, have reviewed the most recent scientific evidence related to the preventive diagnostic management of NP in patients with HF in primary care setting.

Referencias bibliográficas

  • T.A. McDonagh, M. Adamo, R.S. Gardner, A. Baumbach, M. Böhm, H. Burri, et al., ESC Scientific Document Group 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J., 42 (2021), pp. 3599-3726, 10.1093/eurheartj/ehab368 View PDFGoogle Scholar
  • B. Bozkurt, A.J. Coats, H. Tsutsui, M. Abdelhamid, S. Adamopoulos, N. Albert, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association Eur J Heart Fail., 23 (2021), pp. 352-380, 10.1002/ejhf.2115
  • P.M. Seferović, P. Vardas, E.A. Jankowska, A.P. Maggioni, A. Timmis, I. Milinković, et al. The Heart Failure Association atlas: Heart failure epidemiology and management statistics 2019 Eur J Heart Fail., 23 (2021), pp. 906-914, 10.1002/ejhf.2143 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • P.A. Heidenreich, B. Bozkurt, D. Aguilar, L.A. Allen, J.J. Byun, M.M. Colvin, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines J Am Coll Cardiol., 79 (2022), pp. 1757-1780, 10.1016/j.jacc.2021.12.011 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M.J. Castillo-Moraga, M. Turégano-Yedro, V. Pallarés-Carratalá, M.C. Seoane-Vicente, A. Serrano-Cumplido, A. Ruiz-García, et al., Grupo de Trabajo de Hipertensión Arterial y Enfermedad Cardiovascular de SEMERGEN Posicionamiento de SEMERGEN sobre el abordaje de la insuficiencia cardiaca crónica en atención primaria Semergen., 48 (2022), pp. 106-123, 10.1016/j.semerg.2021.10.007 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Volpe Natriuretic peptides and cardio-renal disease Int J Cardiol., 176 (2014), pp. 630-639, 10.1016/j.ijcard.2014.08.032 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Galán-Ortega, E. Guillén-Campuzano Marcadores bioquímicos en la insuficiencia cardíaca congestiva Ed Cont Lab Clín., 17 (2014), pp. 1-15 Disponible en: https://scholar.google.com/scholar?hl=es&as_sdt=0%2C5&q=MARCADORES+BIOQU%C3%8DMICOS+EN+LA+INSUFICIENCIA+CARD%C3%8DACA+CONGESTIVA&btnG= View Record in ScopusGoogle Scholar
  • A. Mallick, J.L. Januzzi Jr. Biomarcadores en la insuficiencia cardiaca aguda Rev Esp Cardiol., 68 (2015), pp. 514-525, 10.1016/j.recesp.2015.02.009 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Anguita, A. Bayes-Genis, J.M. Cepeda, S. Cinza, J. Cosin, M. Crespo-Leiro, et al. Consenso de expertos sobre la insuficiencia cardiaca con fracción de eyección reducida: más allá de las guías Rev Esp Cardiol., 20 (Supl B) (2020), pp. 1-46, 10.1016/S1131-3587(20)30016-9 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M.A. Esteve-Pastor, V. Roldán, J.M. Rivera-Caravaca, I. Ramírez-Macías, G.Y.H. Lip, F. Marín The use of biomarkers in clinical management guidelines: A critical appraisal Thromb Haemost., 119 (2019), pp. 1901-1919, 10.1055/s-0039-1696955 View PDFView Record in ScopusGoogle Scholar
  • A. Salzano, A.M. Marra, R. d’Assante, M. Arcopinto, E. Bossone, T. Suzuki, et al. Biomarkers and imaging: Complementary or subtractive? Heart Fail Clin., 15 (2019), pp. 321-331, 10.1016/j.hfc.2018.12.008 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Metra, G. Cotter, B.A. Davison, G.M. Felker, G. Filippatos, B.H. Greenberg, et al., RELAX-AHF Investigators Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: Correlation with outcomes J Am Coll Cardiol., 61 (2013), pp. 196-206, 10.1016/j.jacc.2012.11.005 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E. Santas, P. Palau, A. Bayés-Genis, J. Núñez The emerging role of carbohydrate antigen 125 in heart failure Biomark Med., 14 (2020), pp. 249-252, 10.2217/bmm-2019-0470 View PDFView Record in ScopusGoogle Scholar
  • P. Llàcer, A. Bayés-Genís, J. Núñez Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatment Med Clin., 152 (2019), pp. 266-273, 10.1016/j.medcli.2018.08.020 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P. Lourenço, F.M. Cunha, C. Elias, C. Fernandes, I. Barroso, J.T. Guimarães, et al. CA-125 variation in acute heart failure: A single-centre analysis ESC Heart Fail. (2022), 10.1002/ehf2.13758 View PDF This article is free to access. Google Scholar
  • C.P. McCarthy, J.L. Januzzi Jr. Soluble ST2 in heart failure Heart Fail Clin., 14 (2018), pp. 41-48, 10.1016/j.hfc.2017.08.005 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.L. Januzzi, A. Mebazaa, S. di Somma ST2 and prognosis in acutely decompensated heart failure: The International ST2 Consensus Panel Am J Cardiol., 115 (Suppl 7) (2015), pp. 26B-31B, 10.1016/j.amjcard.2015.01.037 ArticleDownload PDFGoogle Scholar
  • J. Lassus, E. Gayat, C. Mueller, W.F. Peacock, J. Spinar, V.P. Harjola, et al., GREAT-Network Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study Int J Cardiol., 168 (2013), pp. 2186-2194, 10.1016/j.ijcard.2013.01.228 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • D.A. Pascual-Figal, S. Manzano-Fernández, M. Boronat, T. Casas, I.P. Garrido, J.C. Bonaque, et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: Complementary role for risk stratification in acutely decompensated heart failure Eur J Heart Fail., 13 (2011), pp. 718-725, 10.1093/eurjhf/hfr047 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • I. Bošnjak, K. Selthofer-Relatić, A. Včev Prognostic value of galectin-3 in patients with heart failure Dis Markers., 2015 (2015), p. 690205, 10.1155/2015/690205 View PDFView Record in ScopusGoogle Scholar
  • R.R. Van Kimmenade, J.L. Januzzi Jr., P.T. Ellinor, U.C. Sharma, J.A. Bakker, A.F. Low, et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol., 48 (2006), pp. 1217-1224, 10.1016/j.jacc.2006.03.061 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Möckel, J. Searle, A. Maisel The role of procalcitonin in acute heart failure patients ESC Heart Fail., 4 (2017), pp. 203-208, 10.1002/ehf2.12189 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • A. Maisel, S.X. Neath, J. Landsberg, C. Mueller, R.M. Nowak, W.F. Peacock, et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) trial Eur J Heart Fail., 14 (2012), pp. 278-286, 10.1093/eurjhf/hfr177 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • R.R.J. Van Kimmenade, J.L. Januzzi Jr., A.L. Baggish, J.G. Lainchbury, A. Bayes-Genis, A.M. Richards, et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: Redefining the cardiorenal interaction? J Am Coll Cardiol., 48 (2006), pp. 1621-1627, 10.1016/j.jacc.2006.06.056 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S. Manzano-Fernández, J.L. Januzzi Jr., M. Boronat-Garcia, J.C. Bonaque-González, Q.A. Truong, F.J. Pastor-Pérez, et al. β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure J Am Coll Cardiol., 57 (2011), pp. 849-858, 10.1016/j.jacc.2010.08.644 ArticleDownload PDFGoogle Scholar
  • A. Palazzuoli, M. Beltrami, M. Pellegrini, R. Nuti Natriuretic peptides and NGAL in heart failure: Does a link exist? Clin Chim Acta., 413 (2012), pp. 1832-1838, 10.1016/j.cca.2012.07.010 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • R.A. Booth, S.A. Hill, A. Don-Wauchope, P.L. Santaguida, M. Oremus, R. McKelvie, et al. Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: A systematic review Heart Fail Rev., 19 (2014), pp. 439-451, 10.1007/s10741-014-9445-8 View PDF Your institution provides access to this article. View Record in ScopusGoogle Scholar
  • J.M. Verdú, J. Comín-Colet, M. Domingo, J. Lupón, M. Cómez, M. Molina, et al. Punto de corte óptimo de NT-proBNP para el diagnóstico de insuficiencia cardiaca mediante un test de determinación rápida en atención primaria Rev Esp Cardiol., 65 (2012), pp. 613-619, 10.1016/j.recesp.2012.01.019 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • T.A. Buchan, C. Ching, F. Foroutan, A. Malik, J.F. Daza, N.N.F. Hing, et al. Prognostic value of natriuretic peptides in heart failure: Systematic review and meta-analysis Heart Fail Rev., 27 (2022), pp. 645-654, 10.1007/s10741-021-10136-3 View PDF Your institution provides access to this article. View Record in ScopusGoogle Scholar
  • M.A. Alpert Natriuretic peptides as predictors of cardiovascular events and all-cause mortality J Am Coll Cardiol., 77 (2021), pp. 572-574, 10.1016/j.jacc.2020.12.006 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.M. Verdú-Rotellar, E. Frigola-Capell, R. Álvarez-Pérez, D. da Silva, C. Enjuanes, M. Domingo, et al. Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study Eur J Gen Pract., 23 (2017), pp. 107-113, 10.1080/13814788.2017.1305104 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • A. Zaphiriou, S. Robb, T. Murray-Thomas, G. Mendez, K. Fox, T. McDonagh, et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study Eur J Heart Fail., 7 (2005), pp. 537-541, 10.1016/j.ejheart.2005.01.022 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • D.A. Pascual-Figal, J. Casademont, J.M. Lobos, P. Piñera, A. Bayés-Genis, J. Ordóñez-Llanos, et al. Consensus document and recommendations on the use of natriuretic peptides in clinical practice Rev Clin Esp., 216 (2016), pp. 313-322, 10.1016/j.rce.2016.02.008 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • N.E. Ibrahim, J.C. Burnett Jr., J. Butler, A. Camacho, G.M. Felker, M. Fiuzat, et al. Natriuretic peptides as inclusion criteria in clinical trials: A JACC: Heart Failure Position Paper JACC Heart Fail., 8 (2020), pp. 347-358, 10.1016/j.jchf.2019.12.010 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E. Roberts, A.J. Ludman, K. Dworzynski, A. Al-Mohammad, M.R. Cowie, McMurray, et al., NICE Guideline Development Group for Acute Heart Failure The diagnostic accuracy of the natriuretic peptides in heart failure: Systematic review and diagnostic meta-analysis in the acute care setting BMJ., 350 (2015), p. h910, 10.1136/bmj.h910 View PDFView Record in ScopusGoogle Scholar
  • J.M. Lobos-Bejarano, C. Horrillo-García, A.I. González-González, A. Castellanos-Rodríguez, S. Díaz-Sánchez, J. Castellanos Maroto, et al. Validez y utilidad del péptido ventricular natriuréticos tipo B (BNP) en la detección de disfunción ventricular izquierda en pacientes de alto riesgo en atención primaria Aten Primaria., 44 (2012), pp. 13-19, 10.1016/j.aprim.2010.12.009 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S.J. Baratta, A.N. Atamañuk, J.C. Santucci, S.V. Perrones Rol de los péptidos natriuréticos en insuficiencia cardíaca. El fino equilibrio entre la medicina de precisión y la optimización de los recursos Insuf Card., 16 (2021), pp. 90-96 Disponible en: http://www.scielo.org.ar/scielo.php?pid=S1852-38622021000300004&script=sci_abstract&tlng=en View Record in ScopusGoogle Scholar
  • H. Li, Z. Zeng, J. Cheng, G. Hu, Y. Li, L. Wei, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis Int J Chron Obstruct Pulmon Dis., 15 (2020), pp. 57-67 Google Scholar
  • R. Pavasini, G. Tavazzi, S. Biscaglia, F. Federico Guerra, A. Pecoraro, F. Zarake, et al. Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis Chron Respir Dis., 14 (2017), pp. 117-126, 10.1177/1479972316674393 View PDFView Record in ScopusGoogle Scholar
  • K.N. Bachmann, D.K. Gupta, M. Xu, E. Brittain, E. Farber-Eger, P. Arora, et al. Unexpectedly low natriuretic peptide levels in patients with heart failure JACC Heart Fail., 9 (2021), pp. 192-200, 10.1016/j.jchf.2020.10.008 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • H.I. Choi, M.Y. Lee, B.K. Oh, S.J. Lee, J.G. Kang, S.H. Lee, et al. Effects of age, sex and obesity on N-terminal pro B-type natriuretic peptide concentrations in the general population Circ J., 85 (2021), pp. 647-654, 10.1253/circj.CJ-20-1104 View PDFView Record in ScopusGoogle Scholar
  • N. Suthahar, W.C. Meijers, J.E. Ho, R.T. Gansevoort, A.A. Voors, P. van der Meer, et al. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population Eur J Heart Fail., 20 (2018), pp. 1205-1214, 10.1002/ejhf.1209 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • M. Heras Utilidad clínica del NT-PRO-BNP en pacientes con insuficiencia renal crónica avanzada y en hemodiálisis Nefrología., 25 (2005), pp. 698-702 Disponible en: https://www.revistanefrologia.com/es-utilidad-clinica-del-nt-probnp-en-articulo-X0211699505019449 Google Scholar
  • L. Gromadziński, B. Januszko-Giergielewicz, K. Czarnacka, P. Pruszczyk NT-proBNP in the prognosis of death or need for renal replacement therapy in patients with stage 3-5 chronic kidney disease Cardiorenal Med., 9 (2019), pp. 125-134, 10.1159/000496238 View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • M.F. Sinner, K.A. Stepas, C.B. Moser, B.P. Krijthe, T. Aspelund, N. Sotoodehnia, et al. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: The CHARGE-AF Consortium of community-based cohort studies Europace., 16 (2014), pp. 1426-1433, 10.1093/europace/euu175 View PDFView Record in ScopusGoogle Scholar
  • R. Rørth, P.S. Jhund, M.B. Yilmaz, S.L. Kristensen, P. Welsh, A.S. Desai, et al. Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction Circ Heart Fail., 13 (2020), 10.1161/CIRCHEARTFAILURE.119.006541 e006541 View PDFGoogle Scholar
  • L. Li, E. Selvin, P.L. Lutsey, R.C. Hoogeveen, W.T. O’Neal, E.Z. Soliman, et al. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort Am Heart J., 204 (2018), pp. 119-127, 10.1016/j.ahj.2018.07.008 ArticleDownload PDFGoogle Scholar
  • B. Pieske, C. Tschöpe, R.A. de Boer, A.G. Fraser, S.D. Anker, E. Donal, et al. How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Eur Heart J., 40 (2019), pp. 3297-3317, 10.1093/eurheartj/ehz641 View PDFView Record in ScopusGoogle Scholar
  • H.Y. Choi, M.Y. Lee, B.K. Oh, S.J. Lee, J.G. Kang, S.H. Lee, et al. Fatty liver is associated with low N-terminal pro-B-type natriuretic peptide in a healthy population J Clin Med., 10 (2021), p. 1402, 10.3390/jcm10071402 View PDFView Record in ScopusGoogle Scholar
  • E. Seven, L.L. Husemoen, H. Ibsen, N. Friedrich, M. Nauck, K. Wachtell, et al. Higher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension PLoS One., 10 (2015), 10.1371/journal.pone.0117864 e0117864 View PDFGoogle Scholar
  • M. Rivera, R. Taléns-Visconti, A. Salvador, V. Bertomeu, V. Miró, F. García de Burgos, et al., Grupo de Disfunción VI de la Comunidad Valenciana Hipertensión y valores de NT-proBNP. Su importancia en el diagnóstico de insuficiencia cardíaca Rev Esp Cardiol., 57 (2004), pp. 396-402, 10.1016/S0300-8932(04)77124-9 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Hussain, W. Sun, A. Deswal, J.A. de Lemos, J.W. McEvoy, R.C. Hoogeveen, et al. Association of NT-ProBNP, blood pressure, and cardiovascular events: The ARIC study J Am Coll Cardiol., 77 (2021), pp. 559-571, 10.1016/j.jacc.2020.11.063 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • T. Omland, J.A. de Lemos Amino-terminal pro-B-type natriuretic peptides in stable and unstable ischemic heart disease Am J Cardiol., 101 (2008), pp. 61-66, 10.1016/j.amjcard.2007.11.025 View PDF Your institution provides access to this article. Google Scholar
  • H.H. Liu, Y.X. Cao, J.L. Jin, Y.L. Guo, C.G. Zhu, N.Q. Wu, et al. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: A prospective cohort study Cardiovasc Diabetol., 20 (2021), p. 84, 10.1186/s12933-021-01271-0 View PDF This article is free to access. Google Scholar
  • J. Du Fay de Lavallaz, P. Badertscher, T. Nestelberger, T. Zimmermann, O. Miró, E. Salgado, et al. B-type natriuretic peptides and cardiac troponins for diagnosis and risk-stratification of syncope Circulation., 139 (2019), pp. 2403-2418, 10.1161/CIRCULATIONAHA.118.038358 View PDFView Record in ScopusGoogle Scholar
  • K. Tanimoto, K. Yukiiri, K. Mizushige, Y. Takagi, H. Masugata, K. Shinomiya Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope Am J Cardiol., 93 (2004), pp. 228-230, 10.1016/j.amjcard.2003.09.048 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Pallarés-Carratalá, C. Górriz-Zambrano, C. Morillas-Ariño, J.L. Llisterri-Caro, J.L. Górriz COVID-19 y enfermedad cardiovascular y renal: ¿Dónde estamos? ¿Hacia dónde vamos? Semergen., 46 (Supl 1) (2020), pp. 85-94, 10.1016/j.semerg.2020.05.005 View PDF Your institution provides access to this article. View Record in ScopusGoogle Scholar
  • J.W. Cunningham, B.L. Claggett, K.S. Jering, M. Vaduganathan, A.S. Bhatt, N. Rosenthal, et al. Prognostic value of natriuretic peptides and cardiac troponins in COVID-19 Circulation., 144 (2021), pp. 177-179, 10.1161/CIRCULATIONAHA.121.054969 View PDFView Record in ScopusGoogle Scholar
  • J.J. Qin, X. Cheng, F. Zhou, F. Lei, G. Akolkar, J. Cai, et al. Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 Hypertension., 76 (2020), pp. 1104-1112, 10.1161/HYPERTENSIONAHA.120.15528 View PDFView Record in ScopusGoogle Scholar
  • P. Haaf, G.M. Kuster, C. Mueller, C.T. Berger, P. Monney, P. Burger, et al. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination Swiss Med Wkly., 151 (2021), p. w30087, 10.4414/smw.2021.w30087 View PDFView Record in ScopusGoogle Scholar
  • P. Van der Meer, H.K. Gaggin, G.W. Dec ACC/AHA versus ESC Guidelines on Heart Failure: JACC guideline comparison J Am Coll Cardiol., 73 (2019), pp. 2756-2768, 10.1016/j.jacc.2019.03.478 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S. Sanders-van Wijk, A.D. van Asselt, H. Rickli, W. Estlinbaum, P. Erne, P. Rickenbacher, et al., TIME-CHF Investigators Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: Results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure) JACC Heart Fail., 1 (2013), pp. 64-71, 10.1016/j.jchf.2012.08.002 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • G.W. Moe, J. Howlett, J.L. Januzzi, H. Zowall, Canadian Multicenter Improved Management of Patients with Congestive Heart Failure (IMPROVE-CHF) Study Investigators N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: Primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study Circulation., 115 (2007), pp. 3103-3110, 10.1161/CIRCULATIONAHA.106.666255 View PDFView Record in ScopusGoogle Scholar
  • U. Siebert, J.L. Januzzi Jr., M.T. Beinfeld, R. Cameron, G.S. Gazelle Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department Am J Cardiol., 98 (2006), pp. 800-805, 10.1016/j.amjcard.2006.06.005 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • D. Moertl, S. Steiner, D. Coyle, R. Berger Cost-utility analysis of NT-proBNP-guided multidisciplinary care in chronic heart failure Int J Technol Assess Health Care., 29 (2013), pp. 3-11, 10.1017/S0266462312000712 View PDFView Record in ScopusGoogle Scholar
  • M. Monahan, P. Barton, C.J. Taylor, A.K. Roalfe, F.D.R. Hobbs, M. Cowie, et al. MICE or NICE? An economic evaluation of clinical decision rules in the diagnosis of heart failure in primary care Int J Cardiol., 241 (2017), pp. 255-261, 10.1016/j.ijcard.2017.02.149 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P. Llorens, J. Moreu, F. Pérez-Alcántara, J.M. Rodríguez, C. Crespo Evaluación económica de la determinación del propéptido natriurético cerebral N-terminal (NT-proBNP) en pacientes con disnea en los servicios de urgencias españoles Rev Lab Clin., 5 (2012), pp. 155-164, 10.1016/j.labcli.2012.04.001 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Bhalla, S. Willis, A.S. Maisel B-type natriuretic peptide: The level and the drug-partners in the diagnosis of congestive heart failure Congest Heart Fail., 10 (Suppl 1) (2004), pp. 3-27, 10.1111/j.1527-5299.2004.03310.x View PDF This article is free to access. View Record in ScopusGoogle Scholar
  • R.W. Troughton, C.M. Frampton, H.P. Brunner-la Rocca, M. Pfisterer, L.W. Eurlings, H. Erntell, et al. Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: An individual patient meta-analysis Eur Heart J., 35 (2014), pp. 1559-1567, 10.1093/eurheartj/ehu090 View PDFView Record in ScopusGoogle Scholar
  • M.A. Muñoz, J. Real, J.L. del Val, E. Vinyoles, X. Mundet, M. Domingo, et al. Impact of the sustained control of cardiovascular risk factors on first episode heart failure: The relevant role of primary care Eur J Gen Pract., 21 (2015), pp. 224-230, 10.3109/13814788.2015.1049154 View PDF This article is free to access. View Record in ScopusGoogle Scholar
Fuente de los datos: Dialnet